Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence

scientific article published on 9 February 2011

Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.02556-10
P932PMC publication ID3126145
P698PubMed publication ID21307206

P50authorStuart T. NicholQ60415973
P2093author name stringBrian H Bird
Ayan K Chakrabarti
César G Albariño
Bobbie Rae Erickson
Kimberly A Dodd
P2860cites workMfold web server for nucleic acid folding and hybridization predictionQ24498105
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virusQ24541217
Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interestQ24644904
Mutational analysis of the lassa virus promoterQ24673622
Envelope exchange for the generation of live-attenuated arenavirus vaccinesQ27320211
High diversity and ancient common ancestry of lymphocytic choriomeningitis virusQ28730699
Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa FeverQ34148663
Nucleotide sequence conservation at the 3' termini of the virion RNA species of New World and Old World arenaviruses.Q34253643
Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 proteaseQ34485294
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNAQ34574914
Reverse genetics approaches to combat pathogenic arenavirusesQ34596958
Lassa fever. Effective therapy with ribavirinQ34694588
Lassa virusQ35919691
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practiceQ36905074
Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processingQ39868272
Rescue of the prototypic Arenavirus LCMV entirely from plasmidQ40316804
Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypesQ40355385
Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic feversQ40391705
Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease.Q40453546
Efficient bunyavirus rescue from cloned cDNA.Q40487364
Lassa fever: epidemiology, therapy and vaccine development.Q40788225
Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra LeoneQ40903379
Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domainsQ41592314
Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagationQ42066120
The 3' end termini of the Tacaribe arenavirus subgenomic RNAsQ43756937
Lassa feverQ78037746
A single stem-loop structure in Tacaribe arenavirus intergenic region is essential for transcription termination but is not required for a correct initiation of transcription and replicationQ79381623
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectLassa virusQ1806636
P304page(s)4020-4024
P577publication date2011-02-09
P1433published inJournal of VirologyQ1251128
P1476titleEfficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence
P478volume85

Reverse relations

cites work (P2860)
Q26823627Advanced vaccine candidates for Lassa fever
Q38608502Arenavirus Quasispecies and Their Biological Implications
Q37006773Arenavirus reverse genetics for vaccine development
Q34274569Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses
Q64097889Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors
Q38502997Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis
Q94954969Lassa Virus Genetics
Q40056797Lassa Virus Reverse Genetics
Q64073768Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model
Q38959283Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages
Q38818648Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
Q37934045Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses
Q26742028Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses
Q37543755Reverse Genetics Approaches to Control Arenavirus.
Q36276510Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth
Q27305359Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus
Q38069359Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever
Q56913187The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model
Q38748634The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain
Q36588064The search for animal models for Lassa fever vaccine development
Q56576756Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model
Q33723534VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever
Q55385702Xapuri virus, a novel mammarenavirus: natural reassortment and increased diversity between New World viruses.